Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Janani Rangaswami and Peter McCullough.
Connection Strength

8.002
  1. Clinical Context of Dyskalemias Across the Heart Failure Spectrum and Their Associated Adverse Outcomes. JACC Heart Fail. 2019 06; 7(6):533.
    View in: PubMed
    Score: 0.826
  2. Key updates in Cardio-Nephrology from 2018: springboard to a bright Future. Rev Cardiovasc Med. 2018 Dec 30; 19(4):113-116.
    View in: PubMed
    Score: 0.802
  3. Heart Failure in End-Stage Kidney Disease: Pathophysiology, Diagnosis, and Therapeutic Strategies. Semin Nephrol. 2018 11; 38(6):600-617.
    View in: PubMed
    Score: 0.793
  4. Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2. Rev Cardiovasc Med. 2018 Jun 30; 19(2):51-63.
    View in: PubMed
    Score: 0.775
  5. Preeclampsia as a Form of Type 5 Cardiorenal Syndrome: An Underrecognized Entity in Women's Cardiovascular Health. Cardiorenal Med. 2018; 8(2):160-172.
    View in: PubMed
    Score: 0.762
  6. Efficacy of Subcutaneous Versus Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the Details. JACC Heart Fail. 2018 03; 6(3):266-267.
    View in: PubMed
    Score: 0.757
  7. Real or Perceived: Hyperkalemia Is a Major Deterrent for Renin-Angiotensin Aldosterone System Inhibition in Heart Failure. Nephron. 2018; 138(3):173-175.
    View in: PubMed
    Score: 0.745
  8. Resuscitation for the specialty of nephrology: is cardionephrology the answer? Kidney Int. 2018 01; 93(1):25-26.
    View in: PubMed
    Score: 0.741
  9. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis. Expert Rev Cardiovasc Ther. 2020 Dec; 18(12):919-930.
    View in: PubMed
    Score: 0.227
  10. Meta-analysis of outcomes of patients with COVID-19 infection with versus without gastrointestinal symptoms. Proc (Bayl Univ Med Cent). 2020 Jul; 33(3):366-369.
    View in: PubMed
    Score: 0.221
  11. Fulminant Acute Kidney Injury in a Young Patient with Novel Coronavirus 2019. Cardiorenal Med. 2020; 10(4):217-222.
    View in: PubMed
    Score: 0.220
  12. Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection. Rev Cardiovasc Med. 2020 03 30; 21(1):1-7.
    View in: PubMed
    Score: 0.219
  13. Antihypertensive drugs and risk of COVID-19? Lancet Respir Med. 2020 05; 8(5):e29.
    View in: PubMed
    Score: 0.218
  14. Cardiovascular disease care fragmentation in kidney transplantation: a call for action. Kidney Int. 2019 09; 96(3):568-571.
    View in: PubMed
    Score: 0.207
  15. In-Hospital Mortality and Major Adverse Cardiovascular Events after Kidney Transplantation in the United States. Cardiorenal Med. 2019; 9(1):51-60.
    View in: PubMed
    Score: 0.199
  16. Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic Review. Rev Cardiovasc Med. 2018 Jun 30; 19(2):41-49.
    View in: PubMed
    Score: 0.194
  17. Cardionephrology: Proposal for a Futuristic Educational Approach to a Contemporary Need. Cardiorenal Med. 2018; 8(4):296-301.
    View in: PubMed
    Score: 0.049
  18. Detection of Atherosclerotic Cardiovascular Disease in Patients with Advanced Chronic Kidney Disease in the Cardiology and Nephrology Communities. Cardiorenal Med. 2018; 8(4):285-295.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.